MTOR and neoplasm: ERBB3 influences PI3K/AKT/mTOR pathway activation and epithelial−mesenchymal transition (EMT) in CC (45–47), contributing to immune evasion and tumor development, and may interact with immune checkpoints to facilitate tumor escape (48–54).